HEADER TRANSFERASE 12-JAN-17 5UI4 TITLE STRUCTURE OF NME1 COVALENTLY CONJUGATED TO IMIDAZOLE FLUOROSULFATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOSIDE DIPHOSPHATE KINASE A; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: NDP KINASE A,GRANZYME A-ACTIVATED DNASE,GAAD,METASTASIS COMPND 5 INHIBITION FACTOR NM23,NM23-H1,TUMOR METASTATIC PROCESS-ASSOCIATED COMPND 6 PROTEIN; COMPND 7 EC: 2.7.4.6; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: NME1, NDPKA, NM23; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ARYLFLUOROSULFATE, COVALENT, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR D.E.MORTENSON,G.J.BRIGHTY,I.A.WILSON,J.W.KELLY REVDAT 3 04-OCT-23 5UI4 1 REMARK REVDAT 2 24-JAN-18 5UI4 1 JRNL REVDAT 1 17-JAN-18 5UI4 0 JRNL AUTH D.E.MORTENSON,G.J.BRIGHTY,L.PLATE,G.BARE,W.CHEN,S.LI,H.WANG, JRNL AUTH 2 B.F.CRAVATT,S.FORLI,E.T.POWERS,K.B.SHARPLESS,I.A.WILSON, JRNL AUTH 3 J.W.KELLY JRNL TITL "INVERSE DRUG DISCOVERY" STRATEGY TO IDENTIFY PROTEINS THAT JRNL TITL 2 ARE TARGETED BY LATENT ELECTROPHILES AS EXEMPLIFIED BY ARYL JRNL TITL 3 FLUOROSULFATES. JRNL REF J. AM. CHEM. SOC. V. 140 200 2018 JRNL REFN ESSN 1520-5126 JRNL PMID 29265822 JRNL DOI 10.1021/JACS.7B08366 REMARK 2 REMARK 2 RESOLUTION. 2.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0135 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.81 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 3 NUMBER OF REFLECTIONS : 20995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1134 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.82 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1511 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.56 REMARK 3 BIN R VALUE (WORKING SET) : 0.3410 REMARK 3 BIN FREE R VALUE SET COUNT : 91 REMARK 3 BIN FREE R VALUE : 0.3790 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7118 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 156 REMARK 3 SOLVENT ATOMS : 99 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -3.02000 REMARK 3 B22 (A**2) : -0.18000 REMARK 3 B33 (A**2) : -0.29000 REMARK 3 B12 (A**2) : 1.15000 REMARK 3 B13 (A**2) : 0.17000 REMARK 3 B23 (A**2) : 1.63000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.374 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.342 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 19.323 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 7461 ; 0.008 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 7067 ; 0.004 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 10077 ; 1.202 ; 1.935 REMARK 3 BOND ANGLES OTHERS (DEGREES): 16238 ; 1.183 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 880 ; 5.792 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 345 ;35.732 ;23.913 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1260 ;13.804 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 48 ;14.683 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1053 ; 0.070 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8993 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1767 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3580 ; 1.985 ; 5.932 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3579 ; 1.985 ; 5.932 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4465 ; 3.284 ; 8.895 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 4466 ; 3.284 ; 8.895 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3881 ; 2.126 ; 6.199 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 3882 ; 2.125 ; 6.199 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 5612 ; 3.644 ; 9.219 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 8016 ; 5.501 ;46.658 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 8003 ; 5.496 ;46.670 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NCS TYPE: LOCAL REMARK 3 NUMBER OF DIFFERENT NCS PAIRS : 15 REMARK 3 GROUP CHAIN1 RANGE CHAIN2 RANGE COUNT RMS WEIGHT REMARK 3 1 A 13 150 B 13 150 16108 0.05 0.05 REMARK 3 2 A 13 151 C 13 151 16150 0.05 0.05 REMARK 3 3 A 13 150 D 13 150 15988 0.06 0.05 REMARK 3 4 A 13 151 E 13 151 16292 0.05 0.05 REMARK 3 5 A 13 151 F 13 151 16142 0.06 0.05 REMARK 3 6 B 13 150 C 13 150 16012 0.05 0.05 REMARK 3 7 B 13 152 D 13 152 16172 0.06 0.05 REMARK 3 8 B 13 150 E 13 150 16090 0.05 0.05 REMARK 3 9 B 13 150 F 13 150 16030 0.06 0.05 REMARK 3 10 C 13 150 D 13 150 15858 0.05 0.05 REMARK 3 11 C 13 151 E 13 151 16118 0.05 0.05 REMARK 3 12 C 13 151 F 13 151 16244 0.05 0.05 REMARK 3 13 D 13 150 E 13 150 15986 0.05 0.05 REMARK 3 14 D 13 150 F 13 150 15892 0.05 0.05 REMARK 3 15 E 13 151 F 13 151 16124 0.06 0.05 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 5UI4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-JAN-17. REMARK 100 THE DEPOSITION ID IS D_1000225912. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-DEC-16 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22132 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 59.810 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12800 REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.76300 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2HVE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.72 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4.7 MG/ML SOLUTION PROTEIN REMARK 280 -FLUOROSULFATE CONJUGATE COMBINED WITH SOLUTION CONTAINING 0.2 M REMARK 280 NACL, 0.1 M HEPES PH 7.5 AND 30% (V/V) PEG400 IN SITTING DROPS. REMARK 280 CRYSTALS FROZEN IN LN2 STREAM WITHOUT ADDITIONAL CRYOPROTECTANT, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 15660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -101.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -6 REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLU A 152 REMARK 465 MET B -6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 MET C -6 REMARK 465 HIS C -5 REMARK 465 HIS C -4 REMARK 465 HIS C -3 REMARK 465 HIS C -2 REMARK 465 HIS C -1 REMARK 465 HIS C 0 REMARK 465 MET C 1 REMARK 465 ALA C 2 REMARK 465 GLU C 152 REMARK 465 MET D -6 REMARK 465 HIS D -5 REMARK 465 HIS D -4 REMARK 465 HIS D -3 REMARK 465 HIS D -2 REMARK 465 HIS D -1 REMARK 465 HIS D 0 REMARK 465 MET D 1 REMARK 465 ALA D 2 REMARK 465 MET E -6 REMARK 465 HIS E -5 REMARK 465 HIS E -4 REMARK 465 HIS E -3 REMARK 465 HIS E -2 REMARK 465 HIS E -1 REMARK 465 HIS E 0 REMARK 465 MET E 1 REMARK 465 ALA E 2 REMARK 465 GLU E 152 REMARK 465 MET F -6 REMARK 465 HIS F -5 REMARK 465 HIS F -4 REMARK 465 HIS F -3 REMARK 465 HIS F -2 REMARK 465 HIS F -1 REMARK 465 HIS F 0 REMARK 465 MET F 1 REMARK 465 ALA F 2 REMARK 465 GLU F 152 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 52 35.88 -98.06 REMARK 500 ASP A 57 51.65 -105.36 REMARK 500 ILE A 116 -21.39 53.21 REMARK 500 TYR B 52 35.86 -97.61 REMARK 500 ASP B 57 51.84 -103.63 REMARK 500 ILE B 116 -21.03 52.70 REMARK 500 TYR C 52 35.92 -97.54 REMARK 500 ASP C 57 51.47 -104.09 REMARK 500 ILE C 110 -53.96 -120.10 REMARK 500 ILE C 116 -21.78 53.27 REMARK 500 CYS D 4 50.54 -115.90 REMARK 500 TYR D 52 36.01 -98.04 REMARK 500 ASP D 57 50.87 -104.10 REMARK 500 ILE D 116 -21.91 53.34 REMARK 500 TYR E 52 36.30 -98.03 REMARK 500 ASP E 57 52.66 -105.86 REMARK 500 ILE E 116 -22.15 53.85 REMARK 500 TYR F 52 35.97 -98.01 REMARK 500 ASP F 57 51.79 -104.10 REMARK 500 ILE F 116 -22.10 53.64 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue A7Z A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide A7Z B 201 and LYS B REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide A7Z C 201 and LYS C REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide A7Z D 201 and LYS D REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide A7Z E 201 and LYS E REMARK 800 12 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide A7Z F 201 and LYS F REMARK 800 12 DBREF 5UI4 A 1 152 UNP P15531 NDKA_HUMAN 1 152 DBREF 5UI4 B 1 152 UNP P15531 NDKA_HUMAN 1 152 DBREF 5UI4 C 1 152 UNP P15531 NDKA_HUMAN 1 152 DBREF 5UI4 D 1 152 UNP P15531 NDKA_HUMAN 1 152 DBREF 5UI4 E 1 152 UNP P15531 NDKA_HUMAN 1 152 DBREF 5UI4 F 1 152 UNP P15531 NDKA_HUMAN 1 152 SEQADV 5UI4 MET A -6 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS A -5 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS A -4 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS A -3 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS A -2 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS A -1 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS A 0 UNP P15531 EXPRESSION TAG SEQADV 5UI4 MET B -6 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS B -5 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS B -4 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS B -3 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS B -2 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS B -1 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS B 0 UNP P15531 EXPRESSION TAG SEQADV 5UI4 MET C -6 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS C -5 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS C -4 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS C -3 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS C -2 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS C -1 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS C 0 UNP P15531 EXPRESSION TAG SEQADV 5UI4 MET D -6 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS D -5 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS D -4 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS D -3 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS D -2 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS D -1 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS D 0 UNP P15531 EXPRESSION TAG SEQADV 5UI4 MET E -6 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS E -5 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS E -4 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS E -3 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS E -2 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS E -1 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS E 0 UNP P15531 EXPRESSION TAG SEQADV 5UI4 MET F -6 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS F -5 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS F -4 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS F -3 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS F -2 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS F -1 UNP P15531 EXPRESSION TAG SEQADV 5UI4 HIS F 0 UNP P15531 EXPRESSION TAG SEQRES 1 A 159 MET HIS HIS HIS HIS HIS HIS MET ALA ASN CYS GLU ARG SEQRES 2 A 159 THR PHE ILE ALA ILE LYS PRO ASP GLY VAL GLN ARG GLY SEQRES 3 A 159 LEU VAL GLY GLU ILE ILE LYS ARG PHE GLU GLN LYS GLY SEQRES 4 A 159 PHE ARG LEU VAL GLY LEU LYS PHE MET GLN ALA SER GLU SEQRES 5 A 159 ASP LEU LEU LYS GLU HIS TYR VAL ASP LEU LYS ASP ARG SEQRES 6 A 159 PRO PHE PHE ALA GLY LEU VAL LYS TYR MET HIS SER GLY SEQRES 7 A 159 PRO VAL VAL ALA MET VAL TRP GLU GLY LEU ASN VAL VAL SEQRES 8 A 159 LYS THR GLY ARG VAL MET LEU GLY GLU THR ASN PRO ALA SEQRES 9 A 159 ASP SER LYS PRO GLY THR ILE ARG GLY ASP PHE CYS ILE SEQRES 10 A 159 GLN VAL GLY ARG ASN ILE ILE HIS GLY SER ASP SER VAL SEQRES 11 A 159 GLU SER ALA GLU LYS GLU ILE GLY LEU TRP PHE HIS PRO SEQRES 12 A 159 GLU GLU LEU VAL ASP TYR THR SER CYS ALA GLN ASN TRP SEQRES 13 A 159 ILE TYR GLU SEQRES 1 B 159 MET HIS HIS HIS HIS HIS HIS MET ALA ASN CYS GLU ARG SEQRES 2 B 159 THR PHE ILE ALA ILE LYS PRO ASP GLY VAL GLN ARG GLY SEQRES 3 B 159 LEU VAL GLY GLU ILE ILE LYS ARG PHE GLU GLN LYS GLY SEQRES 4 B 159 PHE ARG LEU VAL GLY LEU LYS PHE MET GLN ALA SER GLU SEQRES 5 B 159 ASP LEU LEU LYS GLU HIS TYR VAL ASP LEU LYS ASP ARG SEQRES 6 B 159 PRO PHE PHE ALA GLY LEU VAL LYS TYR MET HIS SER GLY SEQRES 7 B 159 PRO VAL VAL ALA MET VAL TRP GLU GLY LEU ASN VAL VAL SEQRES 8 B 159 LYS THR GLY ARG VAL MET LEU GLY GLU THR ASN PRO ALA SEQRES 9 B 159 ASP SER LYS PRO GLY THR ILE ARG GLY ASP PHE CYS ILE SEQRES 10 B 159 GLN VAL GLY ARG ASN ILE ILE HIS GLY SER ASP SER VAL SEQRES 11 B 159 GLU SER ALA GLU LYS GLU ILE GLY LEU TRP PHE HIS PRO SEQRES 12 B 159 GLU GLU LEU VAL ASP TYR THR SER CYS ALA GLN ASN TRP SEQRES 13 B 159 ILE TYR GLU SEQRES 1 C 159 MET HIS HIS HIS HIS HIS HIS MET ALA ASN CYS GLU ARG SEQRES 2 C 159 THR PHE ILE ALA ILE LYS PRO ASP GLY VAL GLN ARG GLY SEQRES 3 C 159 LEU VAL GLY GLU ILE ILE LYS ARG PHE GLU GLN LYS GLY SEQRES 4 C 159 PHE ARG LEU VAL GLY LEU LYS PHE MET GLN ALA SER GLU SEQRES 5 C 159 ASP LEU LEU LYS GLU HIS TYR VAL ASP LEU LYS ASP ARG SEQRES 6 C 159 PRO PHE PHE ALA GLY LEU VAL LYS TYR MET HIS SER GLY SEQRES 7 C 159 PRO VAL VAL ALA MET VAL TRP GLU GLY LEU ASN VAL VAL SEQRES 8 C 159 LYS THR GLY ARG VAL MET LEU GLY GLU THR ASN PRO ALA SEQRES 9 C 159 ASP SER LYS PRO GLY THR ILE ARG GLY ASP PHE CYS ILE SEQRES 10 C 159 GLN VAL GLY ARG ASN ILE ILE HIS GLY SER ASP SER VAL SEQRES 11 C 159 GLU SER ALA GLU LYS GLU ILE GLY LEU TRP PHE HIS PRO SEQRES 12 C 159 GLU GLU LEU VAL ASP TYR THR SER CYS ALA GLN ASN TRP SEQRES 13 C 159 ILE TYR GLU SEQRES 1 D 159 MET HIS HIS HIS HIS HIS HIS MET ALA ASN CYS GLU ARG SEQRES 2 D 159 THR PHE ILE ALA ILE LYS PRO ASP GLY VAL GLN ARG GLY SEQRES 3 D 159 LEU VAL GLY GLU ILE ILE LYS ARG PHE GLU GLN LYS GLY SEQRES 4 D 159 PHE ARG LEU VAL GLY LEU LYS PHE MET GLN ALA SER GLU SEQRES 5 D 159 ASP LEU LEU LYS GLU HIS TYR VAL ASP LEU LYS ASP ARG SEQRES 6 D 159 PRO PHE PHE ALA GLY LEU VAL LYS TYR MET HIS SER GLY SEQRES 7 D 159 PRO VAL VAL ALA MET VAL TRP GLU GLY LEU ASN VAL VAL SEQRES 8 D 159 LYS THR GLY ARG VAL MET LEU GLY GLU THR ASN PRO ALA SEQRES 9 D 159 ASP SER LYS PRO GLY THR ILE ARG GLY ASP PHE CYS ILE SEQRES 10 D 159 GLN VAL GLY ARG ASN ILE ILE HIS GLY SER ASP SER VAL SEQRES 11 D 159 GLU SER ALA GLU LYS GLU ILE GLY LEU TRP PHE HIS PRO SEQRES 12 D 159 GLU GLU LEU VAL ASP TYR THR SER CYS ALA GLN ASN TRP SEQRES 13 D 159 ILE TYR GLU SEQRES 1 E 159 MET HIS HIS HIS HIS HIS HIS MET ALA ASN CYS GLU ARG SEQRES 2 E 159 THR PHE ILE ALA ILE LYS PRO ASP GLY VAL GLN ARG GLY SEQRES 3 E 159 LEU VAL GLY GLU ILE ILE LYS ARG PHE GLU GLN LYS GLY SEQRES 4 E 159 PHE ARG LEU VAL GLY LEU LYS PHE MET GLN ALA SER GLU SEQRES 5 E 159 ASP LEU LEU LYS GLU HIS TYR VAL ASP LEU LYS ASP ARG SEQRES 6 E 159 PRO PHE PHE ALA GLY LEU VAL LYS TYR MET HIS SER GLY SEQRES 7 E 159 PRO VAL VAL ALA MET VAL TRP GLU GLY LEU ASN VAL VAL SEQRES 8 E 159 LYS THR GLY ARG VAL MET LEU GLY GLU THR ASN PRO ALA SEQRES 9 E 159 ASP SER LYS PRO GLY THR ILE ARG GLY ASP PHE CYS ILE SEQRES 10 E 159 GLN VAL GLY ARG ASN ILE ILE HIS GLY SER ASP SER VAL SEQRES 11 E 159 GLU SER ALA GLU LYS GLU ILE GLY LEU TRP PHE HIS PRO SEQRES 12 E 159 GLU GLU LEU VAL ASP TYR THR SER CYS ALA GLN ASN TRP SEQRES 13 E 159 ILE TYR GLU SEQRES 1 F 159 MET HIS HIS HIS HIS HIS HIS MET ALA ASN CYS GLU ARG SEQRES 2 F 159 THR PHE ILE ALA ILE LYS PRO ASP GLY VAL GLN ARG GLY SEQRES 3 F 159 LEU VAL GLY GLU ILE ILE LYS ARG PHE GLU GLN LYS GLY SEQRES 4 F 159 PHE ARG LEU VAL GLY LEU LYS PHE MET GLN ALA SER GLU SEQRES 5 F 159 ASP LEU LEU LYS GLU HIS TYR VAL ASP LEU LYS ASP ARG SEQRES 6 F 159 PRO PHE PHE ALA GLY LEU VAL LYS TYR MET HIS SER GLY SEQRES 7 F 159 PRO VAL VAL ALA MET VAL TRP GLU GLY LEU ASN VAL VAL SEQRES 8 F 159 LYS THR GLY ARG VAL MET LEU GLY GLU THR ASN PRO ALA SEQRES 9 F 159 ASP SER LYS PRO GLY THR ILE ARG GLY ASP PHE CYS ILE SEQRES 10 F 159 GLN VAL GLY ARG ASN ILE ILE HIS GLY SER ASP SER VAL SEQRES 11 F 159 GLU SER ALA GLU LYS GLU ILE GLY LEU TRP PHE HIS PRO SEQRES 12 F 159 GLU GLU LEU VAL ASP TYR THR SER CYS ALA GLN ASN TRP SEQRES 13 F 159 ILE TYR GLU HET A7Z A 201 26 HET A7Z B 201 26 HET A7Z C 201 26 HET A7Z D 201 26 HET A7Z E 201 26 HET A7Z F 201 26 HETNAM A7Z 4-[4-(3-METHOXYPHENYL)-1-(PROP-2-YN-1-YL)-1H-IMIDAZOL- HETNAM 2 A7Z 5-YL]PHENYL SULFUROFLUORIDATE FORMUL 7 A7Z 6(C19 H15 F N2 O4 S) FORMUL 13 HOH *99(H2 O) HELIX 1 AA1 LYS A 12 ARG A 18 1 7 HELIX 2 AA2 LEU A 20 GLY A 32 1 13 HELIX 3 AA3 SER A 44 TYR A 52 1 9 HELIX 4 AA4 VAL A 53 LYS A 56 5 4 HELIX 5 AA5 PHE A 60 SER A 70 1 11 HELIX 6 AA6 ASN A 82 GLY A 92 1 11 HELIX 7 AA7 THR A 103 CYS A 109 1 7 HELIX 8 AA8 GLN A 111 ASN A 115 5 5 HELIX 9 AA9 SER A 122 PHE A 134 1 13 HELIX 10 AB1 HIS A 135 LEU A 139 5 5 HELIX 11 AB2 ALA A 146 TYR A 151 1 6 HELIX 12 AB3 LYS B 12 ARG B 18 1 7 HELIX 13 AB4 LEU B 20 GLY B 32 1 13 HELIX 14 AB5 SER B 44 TYR B 52 1 9 HELIX 15 AB6 VAL B 53 LYS B 56 5 4 HELIX 16 AB7 PHE B 60 GLY B 71 1 12 HELIX 17 AB8 ASN B 82 GLY B 92 1 11 HELIX 18 AB9 THR B 103 CYS B 109 1 7 HELIX 19 AC1 GLN B 111 ASN B 115 5 5 HELIX 20 AC2 SER B 122 PHE B 134 1 13 HELIX 21 AC3 HIS B 135 LEU B 139 5 5 HELIX 22 AC4 ALA B 146 TYR B 151 1 6 HELIX 23 AC5 LYS C 12 ARG C 18 1 7 HELIX 24 AC6 LEU C 20 GLY C 32 1 13 HELIX 25 AC7 SER C 44 TYR C 52 1 9 HELIX 26 AC8 VAL C 53 LYS C 56 5 4 HELIX 27 AC9 PHE C 60 SER C 70 1 11 HELIX 28 AD1 ASN C 82 GLY C 92 1 11 HELIX 29 AD2 THR C 103 CYS C 109 1 7 HELIX 30 AD3 GLN C 111 ASN C 115 5 5 HELIX 31 AD4 SER C 122 PHE C 134 1 13 HELIX 32 AD5 HIS C 135 LEU C 139 5 5 HELIX 33 AD6 ALA C 146 TYR C 151 1 6 HELIX 34 AD7 LYS D 12 ARG D 18 1 7 HELIX 35 AD8 LEU D 20 GLY D 32 1 13 HELIX 36 AD9 SER D 44 TYR D 52 1 9 HELIX 37 AE1 VAL D 53 LYS D 56 5 4 HELIX 38 AE2 PHE D 60 GLY D 71 1 12 HELIX 39 AE3 ASN D 82 GLY D 92 1 11 HELIX 40 AE4 THR D 103 CYS D 109 1 7 HELIX 41 AE5 GLN D 111 ASN D 115 5 5 HELIX 42 AE6 SER D 122 PHE D 134 1 13 HELIX 43 AE7 HIS D 135 LEU D 139 5 5 HELIX 44 AE8 ALA D 146 TYR D 151 1 6 HELIX 45 AE9 LYS E 12 ARG E 18 1 7 HELIX 46 AF1 LEU E 20 GLY E 32 1 13 HELIX 47 AF2 SER E 44 TYR E 52 1 9 HELIX 48 AF3 VAL E 53 LYS E 56 5 4 HELIX 49 AF4 PHE E 60 GLY E 71 1 12 HELIX 50 AF5 ASN E 82 GLY E 92 1 11 HELIX 51 AF6 THR E 103 CYS E 109 1 7 HELIX 52 AF7 GLN E 111 ASN E 115 5 5 HELIX 53 AF8 SER E 122 PHE E 134 1 13 HELIX 54 AF9 HIS E 135 LEU E 139 5 5 HELIX 55 AG1 ALA E 146 TYR E 151 1 6 HELIX 56 AG2 LYS F 12 ARG F 18 1 7 HELIX 57 AG3 LEU F 20 GLY F 32 1 13 HELIX 58 AG4 SER F 44 TYR F 52 1 9 HELIX 59 AG5 VAL F 53 LYS F 56 5 4 HELIX 60 AG6 PHE F 60 GLY F 71 1 12 HELIX 61 AG7 ASN F 82 GLY F 92 1 11 HELIX 62 AG8 THR F 103 CYS F 109 1 7 HELIX 63 AG9 GLN F 111 ASN F 115 5 5 HELIX 64 AH1 SER F 122 PHE F 134 1 13 HELIX 65 AH2 HIS F 135 LEU F 139 5 5 HELIX 66 AH3 ALA F 146 TYR F 151 1 6 SHEET 1 AA1 4 ARG A 34 MET A 41 0 SHEET 2 AA1 4 VAL A 73 GLU A 79 -1 O VAL A 77 N VAL A 36 SHEET 3 AA1 4 ARG A 6 ILE A 11 -1 N ILE A 11 O VAL A 74 SHEET 4 AA1 4 ILE A 117 GLY A 119 -1 O HIS A 118 N ALA A 10 SHEET 1 AA2 4 ARG B 34 MET B 41 0 SHEET 2 AA2 4 VAL B 73 GLU B 79 -1 O VAL B 77 N VAL B 36 SHEET 3 AA2 4 ARG B 6 ILE B 11 -1 N ILE B 9 O MET B 76 SHEET 4 AA2 4 ILE B 117 GLY B 119 -1 O HIS B 118 N ALA B 10 SHEET 1 AA3 4 ARG C 34 MET C 41 0 SHEET 2 AA3 4 VAL C 73 GLU C 79 -1 O VAL C 77 N VAL C 36 SHEET 3 AA3 4 ARG C 6 ILE C 11 -1 N ILE C 11 O VAL C 74 SHEET 4 AA3 4 ILE C 117 GLY C 119 -1 O HIS C 118 N ALA C 10 SHEET 1 AA4 4 ARG D 34 MET D 41 0 SHEET 2 AA4 4 VAL D 73 GLU D 79 -1 O VAL D 77 N VAL D 36 SHEET 3 AA4 4 ARG D 6 ILE D 11 -1 N ILE D 9 O MET D 76 SHEET 4 AA4 4 ILE D 117 GLY D 119 -1 O HIS D 118 N ALA D 10 SHEET 1 AA5 4 ARG E 34 MET E 41 0 SHEET 2 AA5 4 VAL E 73 GLU E 79 -1 O VAL E 77 N VAL E 36 SHEET 3 AA5 4 ARG E 6 ILE E 11 -1 N ILE E 11 O VAL E 74 SHEET 4 AA5 4 ILE E 117 GLY E 119 -1 O HIS E 118 N ALA E 10 SHEET 1 AA6 4 ARG F 34 MET F 41 0 SHEET 2 AA6 4 VAL F 73 GLU F 79 -1 O VAL F 77 N VAL F 36 SHEET 3 AA6 4 ARG F 6 ILE F 11 -1 N ILE F 11 O VAL F 74 SHEET 4 AA6 4 ILE F 117 GLY F 119 -1 O HIS F 118 N ALA F 10 LINK NZ LYS A 12 S A7Z A 201 1555 1555 1.60 LINK NZ LYS B 12 S A7Z B 201 1555 1555 1.60 LINK NZ LYS C 12 S A7Z C 201 1555 1555 1.60 LINK NZ LYS D 12 S A7Z D 201 1555 1555 1.60 LINK NZ LYS E 12 S A7Z E 201 1555 1555 1.60 LINK NZ LYS F 12 S A7Z F 201 1555 1555 1.60 SITE 1 AC1 10 LYS A 12 TYR A 52 PHE A 60 GLY A 63 SITE 2 AC1 10 LEU A 64 VAL A 112 GLY A 113 ASN A 115 SITE 3 AC1 10 HIS A 118 GLU B 152 SITE 1 AC2 20 ALA B 10 ILE B 11 PRO B 13 ASP B 14 SITE 2 AC2 20 GLY B 15 VAL B 16 TYR B 52 ARG B 58 SITE 3 AC2 20 PHE B 60 GLY B 63 LEU B 64 TYR B 67 SITE 4 AC2 20 MET B 68 VAL B 112 GLY B 113 ASN B 115 SITE 5 AC2 20 ILE B 116 ILE B 117 HIS B 118 GLU D 124 SITE 1 AC3 20 ALA C 10 ILE C 11 PRO C 13 ASP C 14 SITE 2 AC3 20 GLY C 15 VAL C 16 TYR C 52 PHE C 60 SITE 3 AC3 20 GLY C 63 LEU C 64 TYR C 67 MET C 68 SITE 4 AC3 20 THR C 94 VAL C 112 GLY C 113 ASN C 115 SITE 5 AC3 20 ILE C 116 ILE C 117 HIS C 118 ASP E 57 SITE 1 AC4 18 ALA D 10 ILE D 11 PRO D 13 ASP D 14 SITE 2 AC4 18 GLY D 15 VAL D 16 TYR D 52 LEU D 55 SITE 3 AC4 18 PHE D 60 GLY D 63 LEU D 64 TYR D 67 SITE 4 AC4 18 THR D 94 VAL D 112 ASN D 115 ILE D 116 SITE 5 AC4 18 ILE D 117 HIS D 118 SITE 1 AC5 18 ALA E 10 ILE E 11 PRO E 13 ASP E 14 SITE 2 AC5 18 GLY E 15 VAL E 16 TYR E 52 PHE E 60 SITE 3 AC5 18 GLY E 63 LEU E 64 TYR E 67 THR E 94 SITE 4 AC5 18 VAL E 112 GLY E 113 ASN E 115 ILE E 116 SITE 5 AC5 18 ILE E 117 HIS E 118 SITE 1 AC6 21 ASP A 57 GLU D 152 ALA F 10 ILE F 11 SITE 2 AC6 21 PRO F 13 ASP F 14 GLY F 15 VAL F 16 SITE 3 AC6 21 TYR F 52 ARG F 58 PHE F 60 GLY F 63 SITE 4 AC6 21 LEU F 64 TYR F 67 MET F 68 VAL F 112 SITE 5 AC6 21 GLY F 113 ASN F 115 ILE F 116 ILE F 117 SITE 6 AC6 21 HIS F 118 CRYST1 60.462 68.058 69.682 113.65 98.20 112.46 P 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016539 0.006837 0.006674 0.00000 SCALE2 0.000000 0.015899 0.009132 0.00000 SCALE3 0.000000 0.000000 0.016720 0.00000